We have previously shown that Opa1+/− mice are more susceptible to arterial hypertension (Robert et al., 2021) and that FMD is selectively reduced in a mouse model with Opa1 deficiency in ECs only (EC‐Opa1 mice) (Chehaitly et al., 2022). This evidence concerns the gene OPA1 and Hypertension.